275 related articles for article (PubMed ID: 32829467)
41. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].
Chen C; Zhang XR; Ju ZY; He WF
Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):471-475. PubMed ID: 32114747
[TBL] [Abstract][Full Text] [Related]
42. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
43. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
44. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
Ye Q; Wang B; Mao J
J Infect; 2020 Jun; 80(6):607-613. PubMed ID: 32283152
[TBL] [Abstract][Full Text] [Related]
45. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
Park HH; Kim HN; Kim H; Yoo Y; Shin H; Choi EY; Bae JS; Lee W
Sci Adv; 2020 Jul; 6(31):. PubMed ID: 32937590
[TBL] [Abstract][Full Text] [Related]
46. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
[No Abstract] [Full Text] [Related]
47. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).
Parra-Izquierdo I; Aslan JE
Semin Thromb Hemost; 2020 Oct; 46(7):826-830. PubMed ID: 32882716
[No Abstract] [Full Text] [Related]
48. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Foldes D; Hinton R; Arami S; Bain BJ
Am J Hematol; 2020 Jul; 95(7):861-862. PubMed ID: 32298486
[No Abstract] [Full Text] [Related]
49. A plea for the pathogenic role of immune complexes in severe Covid-19.
Vuitton DA; Vuitton L; Seillès E; Galanaud P
Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
[No Abstract] [Full Text] [Related]
50. Prone positioning in awake non-ICU patients with ARDS caused by COVID-19.
Taboada M; Rodríguez N; Riveiro V; Baluja A; Atanassoff PG
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):581-583. PubMed ID: 32828956
[No Abstract] [Full Text] [Related]
51. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
Hoiland RL; Stukas S; Cooper J; Thiara S; Chen LYC; Biggs CM; Hay K; Lee AYY; Shojania K; Abdulla A; Wellington CL; Sekhon MS
Br J Haematol; 2020 Aug; 190(3):e150-e154. PubMed ID: 32584416
[No Abstract] [Full Text] [Related]
52. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
[TBL] [Abstract][Full Text] [Related]
53. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
Buszko M; Park JH; Verthelyi D; Sen R; Young HA; Rosenberg AS
Nat Immunol; 2020 Oct; 21(10):1146-1151. PubMed ID: 32855555
[No Abstract] [Full Text] [Related]
54. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi Y
Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
[No Abstract] [Full Text] [Related]
55. Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute Respiratory Distress Syndrome.
Haudebourg AF; Perier F; Tuffet S; de Prost N; Razazi K; Mekontso Dessap A; Carteaux G
Am J Respir Crit Care Med; 2020 Jul; 202(2):287-290. PubMed ID: 32479162
[No Abstract] [Full Text] [Related]
56. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
Jialal I; Devaraj S
Ann Clin Lab Sci; 2020 Sep; 50(5):703-705. PubMed ID: 33067221
[No Abstract] [Full Text] [Related]
57. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.
Yiğenoğlu TN; Ulas T; Dal MS; Korkmaz S; Erkurt MA; Altuntaş F
Transfus Apher Sci; 2020 Aug; 59(4):102855. PubMed ID: 32636114
[TBL] [Abstract][Full Text] [Related]
58. Viral and host factors related to the clinical outcome of COVID-19.
Zhang X; Tan Y; Ling Y; Lu G; Liu F; Yi Z; Jia X; Wu M; Shi B; Xu S; Chen J; Wang W; Chen B; Jiang L; Yu S; Lu J; Wang J; Xu M; Yuan Z; Zhang Q; Zhang X; Zhao G; Wang S; Chen S; Lu H
Nature; 2020 Jul; 583(7816):437-440. PubMed ID: 32434211
[TBL] [Abstract][Full Text] [Related]
59. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
60. On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Henderson LA; Canna SW; Schulert GS; Volpi S; Lee PY; Kernan KF; Caricchio R; Mahmud S; Hazen MM; Halyabar O; Hoyt KJ; Han J; Grom AA; Gattorno M; Ravelli A; De Benedetti F; Behrens EM; Cron RQ; Nigrovic PA
Arthritis Rheumatol; 2020 Jul; 72(7):1059-1063. PubMed ID: 32293098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
